The botulinum toxin market is projected to grow from US$ 3.41 billion in 2021 to US$ 5.68 billion in 2028 at a CAGR of 7.6 per cent in the 2021-2028 period.The global botulinum toxin market size was US$ 3.20 billion in 2020.This information was published by Fortune Business Insights in its report titled,“Botulinum Toxin Market, 2021-2028.”The rise in demand for cosmetic non-invasive surgical processes, novel product unveilings, surging flexible income, and alterations in compensation guidelines to afford botulinum injections are the prime factors that drive the market growth. The increase in the demand for this method has also resulted in a substantial effect on the providers of dermatological provisions as well as other non-invasive techniques. Several pharmaceutical companies engaged in this field are progressively presenting products to satisfy the rising demand for botulinum toxin. This is expected to bolster the botulinum toxin market growth. North America held the maximum botulinum toxin market shares and stood at USD 2.15 billion in 2020 owing to the hugely conscious and financially sturdy population along with a reasonably greater number of operative measures conducted in the region.